FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1956002: Buclizine hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
4379013 Buclizine hydrochloride en Synonym Active Entire term case insensitive SNOMED CT core module
747815011 Buclizine hydrochloride (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Buclizine hydrochloride Is a Product containing buclizine false Inferred relationship Existential restriction modifier
Buclizine hydrochloride Is a Sedating antihistamine false Inferred relationship Existential restriction modifier
Buclizine hydrochloride Is a Buclizine false Inferred relationship Existential restriction modifier
Buclizine hydrochloride Has disposition Histamine receptor antagonist true Inferred relationship Existential restriction modifier
Buclizine hydrochloride Is modification of Buclizine true Inferred relationship Existential restriction modifier
Buclizine hydrochloride Is a Benzene derivative hydrocarbon true Inferred relationship Existential restriction modifier
Buclizine hydrochloride Is a Substance with histamine receptor antagonist mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely buclizine hydrochloride 50 milligram/1 each conventional release oral tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely buclizine hydrochloride 50 milligram/1 each conventional release oral tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely buclizine hydrochloride 50 milligram/1 each conventional release oral tablet Has basis of strength substance True Buclizine hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely buclizine hydrochloride 50 milligram/1 each conventional release oral tablet Has precise active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier 1
Generic Migraleve Pink tablets Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 8 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 16 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 32 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 12 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 24 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 48 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 8 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 16 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 32 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 12 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 24 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 48 tablet Has active ingredient False Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 16 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 32 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 32 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 24 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 12 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 8 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 8 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 24 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 48 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Generic Migraleve Pink tablets 12 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 48 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier
Migraleve Pink tablets (Pfizer Consumer Healthcare) 16 tablet Has specific active ingredient True Buclizine hydrochloride Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start